Year: 2023
-
Improving Treatment for Hairy Cell Leukemia
Patients with relapsed or refractory hairy cell leukemia who were treated with vemurafenib experienced excellent response and relapse-free survival, according to a recent clinical trial published in Blood.
-
Novel Cell ‘Switches’ Promote Lung Cancer Growth, Treatment Resistance
Northwestern Medicine investigators have revealed new insights into how cell type switches facilitate tumor growth and treatment resistance in small cell lung cancer, according to findings published in Science Advances.
-
Identifying New Genetic Variants Linked to Heart Failure
Scientists have identified new genes linked to heart failure, according to a study published in Nature Communications.
-
Direct-to-Consumer Online Platforms Expand Access, but Often Fail to Convey Risks of Testosterone Therapy
Direct-to-consumer platforms for testosterone therapy don’t always provide care in concordance with professional guidelines, according to a recent Northwestern Medicine study.
-
Exploring Genetic Regulation of Immunoglobulin A
Increased levels of the antibody immunoglobulin A (IgA) are correlated with the manifestation of several diseases and African ancestry, according to findings published in Nature Communications.
-
Investigating Quality of Life in Large B-cell Lymphoma
Patient-reported outcomes in relapsed or refractory large B-cell lymphoma revealed that receiving CAR T-cell immunotherapy was associated with higher quality of life, according to a recent study.
